International Journal of Hematology

DOI: 10.1007/s12185-013-1421-x Pages: 293-299

Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses

1. Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Department of Hematology and Oncology

Correspondence to:
Yoshinobu Maeda
Tel: +81-86-2357227
Fax: +81-86-2328226



In addition to reduced-intensity conditioning, which has expanded the eligibility for hematopoietic cell transplantation (HCT) to older patients, increased availability of alternative donors, including HLA-mismatched unrelated donors, has increased access to allogeneic HCT for more patients. However, acute graft-versus-host disease (GVHD) remains a lethal complication, even in HLA-matched donor–recipient pairs. The pathophysiology of GVHD depends on aspects of adaptive immunity and interactions between donor T-cells and host dendritic cells (DCs). Recent work has revealed that the role of other immune cells and endothelial cells and components of the innate immune response are also important. Tissue damage caused by the conditioning regimen leads to the release of exogenous and endogenous “danger signals”. Exogenous danger signals called pathogen-associated molecular patterns and endogenous noninfectious molecules known as damage-associated molecular patterns (DAMPs) are responsible for initiating or amplifying acute GVHD by enhancing DC maturation and alloreactive T-cell responses. A significant association of innate immune receptor polymorphisms with outcomes, including GVHD severity, was observed in patients receiving allogeneic HCT. Understanding of the role of innate immunity in acute GVHD might offer new therapeutic approaches.

This article is freely available, click here to access the full text/PDF

Share the Knowledge